Curis (CRIS) EBITDA Margin (2016 - 2025)
Curis' EBITDA Margin history spans 16 years, with the latest figure at 1700.88% for Q4 2025.
- For Q4 2025, EBITDA Margin rose 198841.0% year-over-year to 1700.88%; the TTM value through Dec 2025 reached 80.29%, up 31958.0%, while the annual FY2025 figure was 80.29%, 31958.0% up from the prior year.
- EBITDA Margin reached 1700.88% in Q4 2025 per CRIS's latest filing, up from 243.36% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 1700.88% in Q4 2025 to a low of 799.76% in Q1 2022.
- Average EBITDA Margin over 5 years is 345.94%, with a median of 441.94% recorded in 2021.
- Peak YoY movement for EBITDA Margin: tumbled -34599bps in 2022, then surged 198841bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 437.83% in 2021, then rose by 13bps to 382.27% in 2022, then dropped by -12bps to 429.75% in 2023, then skyrocketed by 33bps to 287.53% in 2024, then skyrocketed by 692bps to 1700.88% in 2025.
- Per Business Quant, the three most recent readings for CRIS's EBITDA Margin are 1700.88% (Q4 2025), 243.36% (Q3 2025), and 312.59% (Q2 2025).